H Malchow

4.8k total citations · 2 hit papers
52 papers, 3.5k citations indexed

About

H Malchow is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, H Malchow has authored 52 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 25 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in H Malchow's work include Inflammatory Bowel Disease (26 papers), Microscopic Colitis (16 papers) and Autoimmune and Inflammatory Disorders (10 papers). H Malchow is often cited by papers focused on Inflammatory Bowel Disease (26 papers), Microscopic Colitis (16 papers) and Autoimmune and Inflammatory Disorders (10 papers). H Malchow collaborates with scholars based in Germany, United Kingdom and Sweden. H Malchow's co-authors include H. Goebell, H Sommer, H. J. Jesdinsky, J W Brandes, Paul Rutgeerts, H. Ehms, Klaus Ewe, H. Lorenz‐Meyer, Subrata Ghosh and F. Gordon and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Gut.

In The Last Decade

H Malchow

50 papers receiving 3.3k citations

Hit Papers

European Cooperative Crohn's Disease Study (ECCDS): Resul... 1984 2026 1998 2012 1984 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Malchow Germany 22 2.6k 2.0k 1.1k 478 323 52 3.5k
Takashi Shimoyama Japan 31 1.5k 0.6× 1.3k 0.6× 1.3k 1.2× 945 2.0× 563 1.7× 136 3.7k
A. Pera Italy 33 2.8k 1.1× 2.3k 1.1× 1.8k 1.6× 474 1.0× 248 0.8× 69 4.3k
Gunnar Olaison Sweden 33 2.1k 0.8× 1.6k 0.8× 2.0k 1.8× 233 0.5× 388 1.2× 75 3.9k
Bruce Yacyshyn United States 29 1.8k 0.7× 1.3k 0.6× 948 0.8× 654 1.4× 857 2.7× 78 3.5k
Yoshitaka Kinouchi Japan 33 1.7k 0.7× 1.1k 0.5× 1.0k 0.9× 890 1.9× 781 2.4× 171 3.6k
Frank Anderson Canada 23 1.5k 0.6× 2.3k 1.1× 969 0.9× 480 1.0× 166 0.5× 64 3.7k
Thomas Ochsenkühn Germany 37 2.8k 1.1× 1.9k 0.9× 1.6k 1.4× 1.5k 3.0× 520 1.6× 99 5.0k
Jean-Paul Achkar United States 24 2.0k 0.8× 1.4k 0.7× 1.2k 1.0× 351 0.7× 397 1.2× 31 2.9k
Gabriele Bianchi Porro Italy 38 2.1k 0.8× 1.6k 0.8× 2.0k 1.8× 236 0.5× 229 0.7× 93 3.8k
Barrett G. Levesque United States 36 3.0k 1.2× 2.3k 1.1× 1.5k 1.4× 679 1.4× 219 0.7× 93 4.0k

Countries citing papers authored by H Malchow

Since Specialization
Citations

This map shows the geographic impact of H Malchow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Malchow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Malchow more than expected).

Fields of papers citing papers by H Malchow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Malchow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Malchow. The network helps show where H Malchow may publish in the future.

Co-authorship network of co-authors of H Malchow

This figure shows the co-authorship network connecting the top 25 collaborators of H Malchow. A scholar is included among the top collaborators of H Malchow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Malchow. H Malchow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Musch, E., Tilo Andus, Wolfgang Kruis, et al.. (2005). Interferon-β-1a for the Treatment of Steroid-Refractory Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. 3(6). 581–586. 51 indexed citations
2.
Armstrong, Victor W., Max Reinshagen, Nicolas von Ahsen, et al.. (2005). A Prospective Evaluation of the Association Between Adverse Drug Reactions to Azathioprine Therapy and Polymorphisms in the Gene Encoding Inosine Triphosphate Pyrophosphatase. Therapeutic Drug Monitoring. 27(2). 245–245. 1 indexed citations
3.
Herfarth, Hans, Tilo Andus, I. Caesar, et al.. (2004). Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization. International Journal of Colorectal Disease. 19(2). 147–152. 25 indexed citations
4.
Ghosh, Subrata, Eran Goldin, F. Gordon, et al.. (2003). Natalizumab for Active Crohn's Disease. New England Journal of Medicine. 348(1). 24–32. 615 indexed citations breakdown →
5.
Malchow, H, et al.. (2002). A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis. Alimentary Pharmacology & Therapeutics. 16(3). 415–423. 38 indexed citations
6.
Hellers, G, Antoine Cortot, Derek P. Jewell, et al.. (1999). Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. Gastroenterology. 116(2). 294–300. 201 indexed citations
7.
Malchow, H. (1997). Crohn's Disease and Escherichia coli. Journal of Clinical Gastroenterology. 25(4). 653–658. 292 indexed citations
8.
Löfberg, Robert, Paul Rutgeerts, H Malchow, et al.. (1996). Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.. Gut. 39(1). 82–86. 157 indexed citations
9.
Rutgeerts, Paul, Robert Löfberg, H Malchow, et al.. (1994). A Comparison of Budesonide with Prednisolone for Active Crohn's Disease. New England Journal of Medicine. 331(13). 842–845. 427 indexed citations
10.
Kaltheuner, Matthias, et al.. (1992). Laser-assisted removal of a foreign body from the colon. Surgical Endoscopy. 6(2). 78–79. 4 indexed citations
12.
Ewe, K., C Herfarth, H Malchow, & H. J. Jesdinsky. (1989). Postoperative Recurrence of Crohn’s Disease in Relation to Radicality of Operation and Sulfasalazine Prophylaxis: A Multicenter Trial. Digestion. 42(4). 224–232. 111 indexed citations
14.
Schmitz-Moormann, P, et al.. (1985). Endoscopic and bioptic study of the upper gastrointestinal tract in crohn’s disease patients. Pathology - Research and Practice. 179(3). 377–387. 68 indexed citations
15.
Ruoff, H. -J., et al.. (1981). Adrenaline Sensitive Adenylate Cyclase in Human Gastric Mucosa. Pharmacology. 23(3). 137–144. 3 indexed citations
16.
Sewing, K.‐Fr., et al.. (1980). Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.. Gut. 21(9). 750–752. 24 indexed citations
17.
Ewe, K., et al.. (1980). [Surgical and internal medicine therapy study of the postoperative prevention of recurrence in Crohn's disease - completion of a partly randomized study].. PubMed. 86. 1327–37. 3 indexed citations
18.
Auer, I. O., et al.. (1979). Immune status in Crohn's disease. Gut. 20(4). 261–268. 54 indexed citations
19.
Dölle, W, et al.. (1976). [Malabsorption caused by HBsAg-positive panareteritis nodosa].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(3). 342–53. 1 indexed citations
20.
Malchow, H, et al.. (1972). Erfolgreiche Behandlung der Candida-Sepsis mit dem oralen Antimykotikum Bay b 5097*. DMW - Deutsche Medizinische Wochenschrift. 97(24). 935–938. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026